SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/26/19 Morgan Stanley 10-K 12/31/18 188:49M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 3.85M 4: EX-10.24 Material Contract HTML 56K 5: EX-10.30 Material Contract HTML 169K 2: EX-10.4 Material Contract HTML 69K 3: EX-10.6 Material Contract HTML 118K 6: EX-21 Subsidiaries List HTML 60K 7: EX-23.1 Consent of Experts or Counsel HTML 64K 8: EX-31.1 Certification -- §302 - SOA'02 HTML 58K 9: EX-31.2 Certification -- §302 - SOA'02 HTML 58K 10: EX-32.1 Certification -- §906 - SOA'02 HTML 53K 11: EX-32.2 Certification -- §906 - SOA'02 HTML 53K 18: R1 Document and Entity Information HTML 82K 19: R2 Consolidated Income Statements HTML 163K 20: R3 Consolidated Comprehensive Income Statements HTML 83K 21: R4 Consolidated Balance Sheets HTML 152K 22: R5 Consolidated Balance Sheets (Parenthetical) HTML 82K 23: R6 Consolidated Statements of Changes in Total Equity HTML 109K 24: R7 Consolidated Statements of Changes in Total Equity HTML 58K (Parenthetical) 25: R8 Consolidated Cash Flow Statements HTML 164K 26: R9 Introduction and Basis of Presentation HTML 74K 27: R10 Significant Accounting Policies HTML 198K 28: R11 Fair Value Disclosures HTML 1.28M 29: R12 Derivative Instruments and Hedging Activities HTML 530K 30: R13 Investment Securities HTML 502K 31: R14 Collateralized Transactions HTML 283K 32: R15 Loans, Lending Commitments and Allowance for HTML 421K Credit Losses 33: R16 Equity Method Investments HTML 70K 34: R17 Goodwill and Intangible Assets HTML 152K 35: R18 Deposits HTML 77K 36: R19 Borrowings and Other Secured Financings HTML 220K 37: R20 Commitments, Guarantees and Contingencies HTML 262K 38: R21 Variable Interest Entities and Securitization HTML 382K Activities 39: R22 Regulatory Requirements HTML 221K 40: R23 Total Equity HTML 379K 41: R24 Earnings per Common Share HTML 119K 42: R25 Interest Income and Interest Expense HTML 90K 43: R26 Deferred Compensation Plans HTML 176K 44: R27 Employee Benefit Plans HTML 391K 45: R28 Income Taxes HTML 215K 46: R29 Segment, Geographic and Revenue Information HTML 426K 47: R30 Parent Company HTML 291K 48: R31 Quarterly Results HTML 251K 49: R32 Subsequent Events HTML 56K 50: R33 Significant Accounting Policies (Policy) HTML 247K 51: R34 Significant Accounting Policies (Tables) HTML 60K 52: R35 Fair Value Disclosures (Tables) HTML 1.21M 53: R36 Derivative Instruments and Hedging Activities HTML 529K (Tables) 54: R37 Investment Securities (Tables) HTML 505K 55: R38 Collateralized Transactions (Tables) HTML 280K 56: R39 Loans, Lending Commitments and Allowance for HTML 416K Credit Losses (Tables) 57: R40 Equity Method Investments (Tables) HTML 69K 58: R41 Goodwill and Intangible Assets (Tables) HTML 156K 59: R42 Deposits (Tables) HTML 77K 60: R43 Borrowings and Other Secured Financings (Tables) HTML 222K 61: R44 Commitments, Guarantees and Contingencies (Tables) HTML 215K 62: R45 Variable Interest Entities and Securitization HTML 357K Activities (Tables) 63: R46 Regulatory Requirements (Tables) HTML 208K 64: R47 Total Equity (Tables) HTML 381K 65: R48 Earnings per Common Share (Tables) HTML 119K 66: R49 Interest Income and Interest Expense (Tables) HTML 88K 67: R50 Deferred Compensation Plans (Tables) HTML 189K 68: R51 Employee Benefit Plans (Tables) HTML 396K 69: R52 Income Taxes (Tables) HTML 216K 70: R53 Segment, Geographic and Revenue Information HTML 433K (Tables) 71: R54 Parent Company (Tables) HTML 289K 72: R55 Quarterly Results (Tables) HTML 253K 73: R56 Significant Accounting Policies (Details) HTML 88K 74: R57 Fair Value Disclosures (Assets and Liabilities HTML 219K Measured at Fair Value on a Recurring Basis) (Details) 75: R58 Fair Value Disclosures (Rollforward of Level 3 HTML 185K Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) 76: R59 Fair Value Disclosures (Valuation Techniques and HTML 366K Sensitivity of Unobservable Inputs Used in Level 3 Fair Value Measurements) (Details) 77: R60 Fair Value Disclosures (Fund Interests Measured HTML 76K Based on Net Asset Value) (Details) 78: R61 Fair Value Disclosures (Borrowings Measured at HTML 69K Fair Value on a Recurring Basis) (Details) 79: R62 Fair Value Disclosures (Earnings Impact of HTML 61K Borrowings under the Fair Value Option) (Details) 80: R63 Fair Value Disclosures (Gains (Losses) Due to HTML 73K Changes in Instrument-Specific Credit Risk) (Details) 81: R64 Fair Value Disclosures (Excess of Contractual HTML 59K Principal Amount Over Fair Value) (Details) 82: R65 Fair Value Disclosures (Fair Value Loans on HTML 57K Nonaccrual Status) (Details) 83: R66 Fair Value Disclosures (Assets and Liabilities HTML 96K Measured at Fair Value on a Nonrecurring Basis) (Details) 84: R67 Fair Value Disclosures (Financial Instruments Not HTML 142K Measured at Fair Value) (Details) 85: R68 Derivative Instruments and Hedging Activities HTML 200K (Derivative Fair Values) (Details) 86: R69 Derivative Instruments and Hedging Activities HTML 123K (Derivative Notionals) (Details) 87: R70 Derivative Instruments and Hedging Activities HTML 81K (Gains (Losses) on Accounting Hedges and Fair Value Hedges) (Details) 88: R71 Derivative Instruments and Hedging Activities HTML 67K (Credit Risk-Related Contingencies) (Details) 89: R72 Derivative Instruments and Hedging Activities HTML 115K (Maximum Potential Payout/Notional of Credit Protection Sold) (Details) 90: R73 Derivative Instruments and Hedging Activities HTML 72K (Fair Value (Asset)/Liability of Credit Protection Sold) (Details) 91: R74 Derivative Instruments and Hedging Activities HTML 68K (Protection Purchased with CDS) (Details) 92: R75 Investment Securities (AFS and HTM Securities) HTML 150K (Details) 93: R76 Investment Securities (Investment Securities in an HTML 158K Unrealized Loss Position) (Details) 94: R77 Investment Securities (Investment Securities by HTML 223K Contractual Maturity) (Details) 95: R78 Investment Securities (Gross Realized Gains and HTML 60K Losses on Sales of AFS Securities) (Details) 96: R79 Collateralized Transactions (Offsetting of Certain HTML 128K Collateralized Transactions) (Details) 97: R80 Collateralized Transactions (Gross Secured HTML 98K Financing Balances) (Details) 98: R81 Collateralized Transactions (Assets Loaned or HTML 60K Pledged) (Details) 99: R82 Collateralized Transactions (Collateral Received) HTML 57K (Details) 100: R83 Collateralized Transactions (Restricted Cash and HTML 61K Segregated Securities) (Details) 101: R84 Collateralized Transactions (Concentration Risk) HTML 61K (Details) 102: R85 Collateralized Transactions (Customer Margin HTML 54K Lending) (Details) 103: R86 Loans, Lending Commitments and Allowance for HTML 141K Credit Losses (Loans by Type) (Details) 104: R87 Loans, Lending Commitments and Allowance for HTML 89K Credit Losses (Impaired Loans and Lending Commitments) (Details) 105: R88 Loans, Lending Commitments and Allowance for HTML 58K Credit Losses (Tdr) (Details) 106: R89 Loans, Lending Commitments and Allowance for HTML 117K Credit Losses (Allowance for Loan Losses and Lending Commitments Rollforward) (Details) 107: R90 Loans, Lending Commitments and Allowance for HTML 64K Credit Losses (Employee Loans) (Details) 108: R91 Equity Method Investments (Equity Method HTML 66K Investment Balances) (Details) 109: R92 Equity Method Investments (Investees) (Details) HTML 64K 110: R93 Goodwill and Intangible Assets (Goodwill HTML 77K Rollforward) (Details) 111: R94 Goodwill and Intangible Assets (Intangible Assets HTML 69K by Business Segment) (Details) 112: R95 Goodwill and Intangible Assets (Gross Amortizable HTML 84K Intangible Assets by Type) (Details) 113: R96 Goodwill and Intangible Assets (Net Amortizable HTML 75K Intangible Assets Rollforward) (Details) 114: R97 Deposits (Details) HTML 78K 115: R98 Borrowings and Other Secured Financings HTML 109K (Maturities and Terms of Borrowings) (Details) 116: R99 Borrowings and Other Secured Financings (Long-Term HTML 76K Borrowings) (Details) 117: R100 Borrowings and Other Secured Financings (Rates for HTML 56K Long-Term Borrowings) (Details) 118: R101 Borrowings and Other Secured Financings (Other HTML 61K Secured Financings) (Details) 119: R102 Borrowings and Other Secured Financings HTML 96K (Maturities and Terms of Secured Financings) (Details) 120: R103 Borrowings and Other Secured Financings (Failed HTML 69K Sales by Maturity) (Details) 121: R104 Commitments, Guarantees and Contingencies HTML 89K (Commitments) (Details) 122: R105 Commitments, Guarantees and Contingencies HTML 78K (Operating Premises Leases) (Details) 123: R106 Commitments, Guarantees and Contingencies HTML 126K (Obligations under Guarantee Arrangements) (Details) 124: R107 Commitments, Guarantees and Contingencies HTML 118K (Contingencies) (Details) 125: R108 Variable Interest Entities and Securitization HTML 65K Activities (Assets and Liabilities by Type of Activity) (Details) 126: R109 Variable Interest Entities and Securitization HTML 90K Activities (Assets and Liabilities by Balance Sheet Caption) (Details) 127: R110 Variable Interest Entities and Securitization HTML 131K Activities (Non-Consolidated VIEs) (Details) 128: R111 Variable Interest Entities and Securitization HTML 100K Activities (Transfers of Assets with Continuing Involvement 1) (Details) 129: R112 Variable Interest Entities and Securitization HTML 85K Activities (Transfers of Assets with Continuing Involvement 2) (Details) 130: R113 Variable Interest Entities and Securitization HTML 64K Activities (Proceeds from New Securitization Transactions and Sales of Loans) (Details) 131: R114 Variable Interest Entities and Securitization HTML 68K Activities (Assets Sold with Retained Exposure) (Details) 132: R115 Regulatory Requirements (Narrative) (Details) HTML 60K 133: R116 Regulatory Requirements (Capital Measures) HTML 97K (Details) 134: R117 Regulatory Requirements (U.S. Bank Subsidiaries' HTML 106K Regulatory Capital and Capital Ratios) (Details) 135: R118 Regulatory Requirements (U.S. Broker-Dealer HTML 62K Regulatory Capital Requirements) (Details) 136: R119 Regulatory Requirements (Restricted Net Assets) HTML 55K (Details) 137: R120 Total Equity (Rollforward of Common Stock HTML 62K Outstanding) (Details) 138: R121 Total Equity (Dividends and Share Repurchases) HTML 79K (Details) 139: R122 Total Equity (Preferred Stock Outstanding) HTML 103K (Details) 140: R123 Total Equity (Preferred Stock Issuance HTML 92K Description) (Details) 141: R124 Total Equity (Preferred Stock Dividends) (Details) HTML 83K 142: R125 Total Equity (Aoci) (Details) HTML 73K 143: R126 Total Equity (Components of Period Changes in OCI HTML 193K ) (Details) 144: R127 Total Equity (Cumulative Adjustments to Retained HTML 68K Earnings) (Details) 145: R128 Total Equity (Cumulative Foreign Currency HTML 63K Translation Adjustments) (Details) 146: R129 Earnings per Common Share (Calculation of Basic HTML 125K and Diluted EPS) (Details) 147: R130 Interest Income and Interest Expense (Details) HTML 87K 148: R131 Deferred Compensation Plans (Stock-based HTML 82K Compensation Plans) (Details) 149: R132 Deferred Compensation Plans (Vested and Unvested HTML 82K RSU Activity) (Details) 150: R133 Deferred Compensation Plans (Unvested RSU HTML 83K Activity) (Details) 151: R134 Deferred Compensation Plans (Performance-Based HTML 73K Stock Units) (Details) 152: R135 Deferred Compensation Plans (Monte Carlo HTML 67K Simulation Assumptions) (Details) 153: R136 Deferred Compensation Plans (Deferred Cash-based HTML 73K Compensation Plans) (Details) 154: R137 Deferred Compensation Plans (Annual Compensation HTML 80K Cost for 2018 Performance Year Awards) (Details) 155: R138 Employee Benefit Plans (Net Periodic Benefit HTML 109K Expense (Income)) (Details) 156: R139 Employee Benefit Plans (Rollforward of the Benefit HTML 119K Obligation and Fair Value of Plan Assets) (Details) 157: R140 Employee Benefit Plans (Accumulated Benefit HTML 65K Obligation, and Pension Plans with Benefit Obligations in Excess of the Fair Value of Plan Assets) (Details) 158: R141 Employee Benefit Plans (Assumptions) (Details) HTML 76K 159: R142 Employee Benefit Plans (Fair Value of Plan Assets) HTML 135K (Details) 160: R143 Employee Benefit Plans (Rollforward of Level 3 HTML 64K Plan Assets) (Details) 161: R144 Employee Benefit Plans (Expected Future Benefit HTML 71K Payments) (Details) 162: R145 Employee Benefit Plans (401(k) and Defined HTML 67K Contribution Pension Plans) (Details) 163: R146 Income Taxes (Provision for (Benefit from) Income HTML 126K Taxes) (Details) 164: R147 Income Taxes (Effective Income Tax Rate) (Details) HTML 92K 165: R148 Income Taxes (Deferred Tax Assets and Liabilities) HTML 84K (Details) 166: R149 Income Taxes (Unrecognized Tax Benefits) (Details) HTML 76K 167: R150 Income Taxes (Earliest Tax Year Subject to HTML 63K Examination in Major Tax Jurisdictions) (Details) 168: R151 Segment, Geographic and Revenue Information HTML 197K (Selected Financial Information by Business Segment) (Details) 169: R152 Segment, Geographic and Revenue Information (Net HTML 80K Discrete Tax Provision (Benefit) by Segment) (Details) 170: R153 Segment, Geographic and Revenue Information HTML 62K (Assets by Business Segment) (Details) 171: R154 Segment, Geographic and Revenue Information HTML 58K (Additional Information - Investment Management) (Details) 172: R155 Segment, Geographic and Revenue Information (Net HTML 67K Revenues by Region) (Details) 173: R156 Segment, Geographic and Revenue Information HTML 64K (Income by Region) (Details) 174: R157 Segment, Geographic and Revenue Information (Total HTML 61K Assets by Region) (Details) 175: R158 Segment, Geographic and Revenue Information HTML 68K (Trading Revenues by Product Type) (Details) 176: R159 Segment, Geographic and Revenue Information HTML 88K (Change in Revenue) (Details) 177: R160 Segment, Geographic and Revenue Information HTML 56K (Receivables from Contracts with Customers) (Details) 178: R161 Parent Company (Condensed Income Statements and HTML 132K Comprehensive Income Statements) (Details) 179: R162 Parent Company (Condensed Balance Sheets) HTML 171K (Details) 180: R163 Parent Company (Condensed Cash Flow Statements) HTML 163K (Details) 181: R164 Parent Company (Long-Term Borrowings) (Details) HTML 65K 182: R165 Parent Company (Guarantees) (Details) HTML 60K 183: R166 Quarterly Results (Unaudited) (Details) HTML 130K 184: R167 Quarterly Results (Unaudited) (Subnote) (Details) HTML 63K 185: R168 Quarterly Results (Change in Revenue) (Details) HTML 63K 187: XML IDEA XML File -- Filing Summary XML 384K 186: EXCEL IDEA Workbook of Financial Reports XLSX 321K 12: EX-101.INS XBRL Instance -- ms-20181231 XML 20.23M 14: EX-101.CAL XBRL Calculations -- ms-20181231_cal XML 652K 15: EX-101.DEF XBRL Definitions -- ms-20181231_def XML 3.52M 16: EX-101.LAB XBRL Labels -- ms-20181231_lab XML 6.42M 17: EX-101.PRE XBRL Presentations -- ms-20181231_pre XML 4.73M 13: EX-101.SCH XBRL Schema -- ms-20181231 XSD 678K 188: ZIP XBRL Zipped Folder -- 0001193125-19-051943-xbrl Zip 1.19M
EX-31.1 |
EXHIBIT 31.1
Certification
I, James P. Gorman, certify that:
1. | I have reviewed this annual report on Form 10-K of Morgan Stanley; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: February 26, 2019
/s/ JAMES P. GORMAN |
Chairman of the Board and Chief Executive Officer |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/26/19 | 4, 424B2, FWP | ||
For Period end: | 12/31/18 | 11-K, 13F-HR, FWP, SC 13G | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/24 Morgan Stanley 10-K 12/31/23 224:45M 2/24/23 Morgan Stanley 10-K 12/31/22 227:50M 2/24/22 Morgan Stanley 10-K 12/31/21 225:51M 2/26/21 Morgan Stanley 10-K 12/31/20 225:50M |